Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

CYP2D6‐debrisoquine hydroxylase gene polymorphism in multiple system atrophy

Identifieur interne : 003989 ( Istex/Curation ); précédent : 003988; suivant : 003990

CYP2D6‐debrisoquine hydroxylase gene polymorphism in multiple system atrophy

Auteurs : V. Planté-Bordeneuve [Royaume-Uni] ; O. Bandmann [Royaume-Uni] ; G. Wenning [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; Harding [Royaume-Uni]

Source :

RBID : ISTEX:A74D2BAFCD624AC24D50C184996E977E8D1C8BCA

English descriptors

Abstract

Molecular genetic studies of the cytochrome P450 system enzyme CYP2D6, which hydroxylates debrisoquine, have indicated an excess of mutant alleles in large series of patients with Parkinosn's disease (PD) when compared with controls. We have investigated CYP2D6 polymorphism in 91 patients with multiple system atrophy (MSA) in order to determine if this finding is specific to PD or if there is similar evidence of genetic susceptibility to neurotoxicity in MSA. The distribution of CYP2D6 alleles was not significantly different between MSA patients and controls, and there were fewer poor metabolisers in the MSA group than in the control group.

Url:
DOI: 10.1002/mds.870100307

Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:A74D2BAFCD624AC24D50C184996E977E8D1C8BCA

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">CYP2D6‐debrisoquine hydroxylase gene polymorphism in multiple system atrophy</title>
<author>
<name sortKey="Plante Ordeneuve, V" sort="Plante Ordeneuve, V" uniqKey="Plante Ordeneuve V" first="V." last="Planté-Bordeneuve">V. Planté-Bordeneuve</name>
<affiliation wicri:level="2">
<mods:affiliation>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London, England</mods:affiliation>
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Bandmann, O" sort="Bandmann, O" uniqKey="Bandmann O" first="O." last="Bandmann">O. Bandmann</name>
<affiliation wicri:level="2">
<mods:affiliation>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London, England</mods:affiliation>
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Wenning, G" sort="Wenning, G" uniqKey="Wenning G" first="G." last="Wenning">G. Wenning</name>
<affiliation wicri:level="2">
<mods:affiliation>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London, England</mods:affiliation>
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Quinn, N P" sort="Quinn, N P" uniqKey="Quinn N" first="N. P." last="Quinn">N. P. Quinn</name>
<affiliation wicri:level="2">
<mods:affiliation>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London, England</mods:affiliation>
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Daniel, S E" sort="Daniel, S E" uniqKey="Daniel S" first="S. E." last="Daniel">S. E. Daniel</name>
<affiliation wicri:level="2">
<mods:affiliation>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London, England</mods:affiliation>
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Harding" sort="Harding" uniqKey="Harding" last="Harding">Harding</name>
<affiliation wicri:level="2">
<mods:affiliation>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London, England</mods:affiliation>
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:A74D2BAFCD624AC24D50C184996E977E8D1C8BCA</idno>
<date when="1995" year="1995">1995</date>
<idno type="doi">10.1002/mds.870100307</idno>
<idno type="url">https://api.istex.fr/document/A74D2BAFCD624AC24D50C184996E977E8D1C8BCA/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003989</idno>
<idno type="wicri:Area/Istex/Curation">003989</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">CYP2D6‐debrisoquine hydroxylase gene polymorphism in multiple system atrophy</title>
<author>
<name sortKey="Plante Ordeneuve, V" sort="Plante Ordeneuve, V" uniqKey="Plante Ordeneuve V" first="V." last="Planté-Bordeneuve">V. Planté-Bordeneuve</name>
<affiliation wicri:level="2">
<mods:affiliation>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London, England</mods:affiliation>
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Bandmann, O" sort="Bandmann, O" uniqKey="Bandmann O" first="O." last="Bandmann">O. Bandmann</name>
<affiliation wicri:level="2">
<mods:affiliation>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London, England</mods:affiliation>
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Wenning, G" sort="Wenning, G" uniqKey="Wenning G" first="G." last="Wenning">G. Wenning</name>
<affiliation wicri:level="2">
<mods:affiliation>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London, England</mods:affiliation>
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Quinn, N P" sort="Quinn, N P" uniqKey="Quinn N" first="N. P." last="Quinn">N. P. Quinn</name>
<affiliation wicri:level="2">
<mods:affiliation>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London, England</mods:affiliation>
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Daniel, S E" sort="Daniel, S E" uniqKey="Daniel S" first="S. E." last="Daniel">S. E. Daniel</name>
<affiliation wicri:level="2">
<mods:affiliation>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London, England</mods:affiliation>
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Harding" sort="Harding" uniqKey="Harding" last="Harding">Harding</name>
<affiliation wicri:level="2">
<mods:affiliation>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London, England</mods:affiliation>
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1995-05">1995-05</date>
<biblScope unit="vol">10</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="277">277</biblScope>
<biblScope unit="page" to="278">278</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">A74D2BAFCD624AC24D50C184996E977E8D1C8BCA</idno>
<idno type="DOI">10.1002/mds.870100307</idno>
<idno type="ArticleID">MDS870100307</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Cytochrome P450</term>
<term>Multiple system atrophy</term>
<term>Parkinson's disease</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Molecular genetic studies of the cytochrome P450 system enzyme CYP2D6, which hydroxylates debrisoquine, have indicated an excess of mutant alleles in large series of patients with Parkinosn's disease (PD) when compared with controls. We have investigated CYP2D6 polymorphism in 91 patients with multiple system atrophy (MSA) in order to determine if this finding is specific to PD or if there is similar evidence of genetic susceptibility to neurotoxicity in MSA. The distribution of CYP2D6 alleles was not significantly different between MSA patients and controls, and there were fewer poor metabolisers in the MSA group than in the control group.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003989 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 003989 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Istex
   |étape=   Curation
   |type=    RBID
   |clé=     ISTEX:A74D2BAFCD624AC24D50C184996E977E8D1C8BCA
   |texte=   CYP2D6‐debrisoquine hydroxylase gene polymorphism in multiple system atrophy
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024